Lantheus Medical Imaging Overview

  • Founded

  • 1956

Founded
  • Status

  • Public

  • Employees

  • 698

Employees
  • Stock Symbol

  • LNTH

Stock Symbol
  • Investments

  • 4

  • Share Price

  • $81.43

  • (As of Friday Closing)

Lantheus Medical Imaging General Information

Description

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Contact Information

Website
www.lantheus.com
Formerly Known As
Bristol-Myers Squibb Medical Imaging, New England Nuclear Corporation
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Stock Exchange
NAS
Primary Office
  • 331 Treble Cove Road
  • North Billerica, MA 01862
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lantheus Medical Imaging Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$81.43 $79.62 $47.46 - $87.47 $5.55B 67.5M 1.02M $0.41

Lantheus Medical Imaging Financials Summary

In Thousands,
USD 		TTM 31-Dec-2022 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 3,433,207 3,433,207 2,041,203 1,036,908
Revenue 935,061 935,061 425,208 339,410
EBITDA 78,191 78,191 (26,631) 21,062
Net Income 28,067 28,067 (71,279) (13,473)
Total Assets 1,321,258 1,321,258 863,784 869,821
Total Debt 583,508 583,508 191,309 235,901
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lantheus Medical Imaging Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lantheus Medical Imaging‘s full profile, request access.

Request a free trial

Lantheus Medical Imaging Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its pro
Other Devices and Supplies
North Billerica, MA
698 As of 2022
00000
000000000 00 00000

000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000000000 000000000
Villepinte, France
0000 As of 0000
00000000

000 00

is nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehender
0000000000 000000000
Melbourne, FL
000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lantheus Medical Imaging Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Guerbet Group Corporation Villepinte, France 0000 00000000
000 0000000 000000 Formerly PE-Backed Melbourne, FL 000 000000000000
00 0000000000 Corporation Boston, MA 00000 00000000
00000000 Venture Capital-Backed Edinburgh, United Kingdom 0 000.00 0000000000 000.00
00000000000 Venture Capital-Backed Beijing, China 000 00000 00000000000 00000
You’re viewing 5 of 13 competitors. Get the full list »

Lantheus Medical Imaging Patents

  • 662

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 27

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Lantheus Medical Imaging Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021322205-A1 Methods and devices for preparation of ultrasound contrast agents Pending 04-Aug-2020 0000000000
CA-3189851-A1 Methods and devices for preparation of ultrasound contrast agents Pending 04-Aug-2020 0000000000
AU-2020268890-A1 Pierceable plug for needle Pending 03-May-2019 00000000
CA-3140037-A1 Pierceable plug for needle Pending 03-May-2019 00000000
US-20220189651-A1 Pierceable plug for needle Pending 03-May-2019 G21G1/0005
To view Lantheus Medical Imaging’s complete patent history, request access »

Lantheus Medical Imaging Executive Team (27)

Name Title Board Seat Contact Info
Mary Heino Chief Executive Officer & Board Member
Paul Blanchfield President
Andrea Sabens Chief Accounting Officer, Accounting
Daniel Niedzwiecki JD Chief Administrative Officer, Administration
Etienne Montagut Executive
You’re viewing 5 of 27 executive team members. Get the full list »

Lantheus Medical Imaging Board Members (19)

Name Representing Role Since
00000 00000000 Self Chairman & Board Member 000 0000
0000 000000 Lantheus Medical Imaging Board Member 000 0000
000000 000 00.0 Self Board Member 000 0000
00000 000000 Lantheus Medical Imaging Board Member 000 0000
00000 000000 00 Self Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Lantheus Medical Imaging Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lantheus Medical Imaging Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 06-Feb-2023 0000000000 Discovery Tools (Healthcare) 0000000 0
00000 0000000 10-Jun-2022 00000 0000 0000 Monitoring Equipment
000000000 000 19-Jun-2020 0000000000 00000 Drug Discovery 0000 0000
Thermocore Medical 18-Nov-2004 Merger/Acquisition Diagnostic Equipment
To view Lantheus Medical Imaging’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Lantheus Medical Imaging Subsidiaries (2)

Company Name Industry Location Founded
Cerveau Technologies Discovery Tools (Healthcare) Knoxville, TN 2016
00000000 0000000 0 Corporate Pension North Billerica, MA 0000
To view Lantheus Medical Imaging’s complete subsidiaries history, request access »

Lantheus Medical Imaging ESG

Risk Overview

Risk Rating

Updated April, 01, 2022

30.15 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,231

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 899

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 431

Rank

00.00

Percentile

To view Lantheus Medical Imaging’s complete esg history, request access »